| My Odyssey |
|
|
| Written by Dr. Mel | |||||||||||
| Tuesday, 28 February 2006 | |||||||||||
Page 9 of 9  Mel and Arlene on the Weather Deck I would be remiss if I didn’t include a few other parts of my treatment – the don’t ask, don’t tell part of the program. None of that is necessarily doctor-approved, and I will leave that for a separate sidebar. Besides, morning twilight is just happening, and Arlene and I never want to miss watching the sunrise from our deck, overlooking Long Island Sound. Our house looks south and east. Amazingly, from the first day of fall to the first day of spring, we can watch the sun come up directly from the ocean surface. Then, from the first day of spring through the summer, the sun shifts far enough to the north so that its initial liftoff is obscured by a point that extends out to the water. Our home is positioned like a local Stonehenge – in total synch with the sun and the seasons. I hope to have a lot of sunrises in the future, a lot of seasons to experience, too. But for now, I just don’t want to miss this one. |
|||||||||||
| < Prev | Next > |
|---|
Multiple Myeloma News Update
-
Immunomedics to Present At 50th ASH Annual Meeting
GlobeNewsWire (press release), CA - 4 hours ago
... Moscone Center, Hall A) --"First Trial of Humanized Anti-CD74 Monoclonal Antibody (MAb), Milatuzumab, in Multiple Myeloma" (Publication No. ... -
Xencor to Present New Data from Pre-Clinical Antibody Programs at ...
MarketWatch - 5 hours ago
... XmAb5485, Exhibits Potent Activity In Vitro and In Vivo Against Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma," on Tuesday, ... -
The International Myeloma Foundation Says Patient Experience ...
MarketWatch - 5 hours ago
Multiple myeloma is a cancer of cells in the bone marrow that affects blood cell production. It cannot be cured, however new therapies used in combination ... -
InforSense Partners With the UK's South London and Maudsley NHS ...
MarketWatch - 9 hours ago
... research into diseases such as Alzheimer's, breast cancer and multiple myeloma," said Jonathan Sheldon, Chief Scientific Officer at InforSense. ...
InforSense Partners With the UK's South London and Maudsley NHS ... International Business Times
all 13 news articles -
Astex presents updates on AT7519 and AT9283 at the American ...
PharmaLive.com (press release), PA - 19 hours ago
Together, these data provide the rationale for further clinical evaluation of AT7519 in the treatment of multiple myeloma and CLL and suggests that AT7519 ... -
Dec 6, 2008 Monthly meeting of the NE TN Multiple Myeloma Support ...
Kingsport Times News, TN - Nov 30, 2008
By Ellen Barrett The Northeast Tennessee Multiple Myeloma Support Group will have it’s next monthly meeting at the Health Resources Center Annex at the Mall ... -
Multiple Myeloma Research Foundation’s (MMRF) annual gala raises ...
Norwalk Plus Magazine - Nov 25, 2008
By Press Release The Multiple Myeloma Research Foundation (MMRF) raised over $1.5 million at its 12th annual "Friends for Life" Fall Gala held on November 1 ... -
HemOncTodayLast decade brought progress in treatment of multiple myeloma
HemOncToday, NJ - Nov 25, 2008
Major strides have been made in the treatment of multiple myeloma in the last decade, with the advent of new agents such as thalidomide, lenalidomide and ...